← Back to Search

Behavioural Intervention

Feasibility trial group for Autism Spectrum Disorder

N/A
Recruiting
Research Sponsored by Thomas Jefferson University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be younger than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 14 weeks
Awards & highlights

Study Summary

This trial adapts an evidence-based occupational therapy intervention to a telehealth delivery model to address the sensory motor symptoms of ASD and measure outcomes in daily activities.

Who is the study for?
This trial is for children aged between 4 and 12 years with Autism Spectrum Disorder (ASD) who show sensory symptoms. Families must be willing to participate in the study, and the children should be physically capable of engaging in active sensorimotor activities.Check my eligibility
What is being tested?
The trial is testing OT4ASD, an occupational therapy intervention adapted for telehealth delivery. It aims to see if this remote therapy helps improve daily living skills in kids with ASD by using tailored sensory motor activities.See study design
What are the potential side effects?
Since OT4ASD involves non-medical interventions like occupational therapy via telehealth, there are no direct medical side effects. However, participants may experience fatigue or frustration during sensorimotor activities.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 14 weeks
This trial's timeline: 3 weeks for screening, Varies for treatment, and up to 14 weeks for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Daily Living Skills Change Score - Pediatric Evaluation of Disabilities Inventory
Pervasive Developmental Disorders Behavioral Inventory T Score Autism Behaviors
Secondary outcome measures
Goal Attainment Scale T Score
Sensory Processing Measure

Trial Design

1Treatment groups
Experimental Treatment
Group I: Feasibility trial groupExperimental Treatment1 Intervention
One group (arm) trial where all will receive treatment.

Find a Location

Who is running the clinical trial?

Montefiore Medical CenterOTHER
445 Previous Clinical Trials
582,616 Total Patients Enrolled
5 Trials studying Autism Spectrum Disorder
154 Patients Enrolled for Autism Spectrum Disorder
Thomas Jefferson UniversityLead Sponsor
446 Previous Clinical Trials
147,979 Total Patients Enrolled
2 Trials studying Autism Spectrum Disorder
724 Patients Enrolled for Autism Spectrum Disorder

Media Library

OT4ASD (Behavioural Intervention) Clinical Trial Eligibility Overview. Trial Name: NCT04832152 — N/A
Autism Spectrum Disorder Research Study Groups: Feasibility trial group
Autism Spectrum Disorder Clinical Trial 2023: OT4ASD Highlights & Side Effects. Trial Name: NCT04832152 — N/A
OT4ASD (Behavioural Intervention) 2023 Treatment Timeline for Medical Study. Trial Name: NCT04832152 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is this research study open to seniors aged 65 years and older?

"As laid out in the study's criteria, patients between 4 and 12 years old are eligible to participate."

Answered by AI

Who is best suited for participation in this clinical experiment?

"Applicants to this clinical trial should have a diagnosed instance of autism spectrum disorder and must be between the ages 4-12. As such, only 10 participants are being accepted."

Answered by AI

How many participants is this clinical trial enrolling?

"Affirmative. According to the details available on clinicaltrials.gov, this medical study is still recruiting patients with a start date of March 1st 2023 and latest edit made June 1st 2023. This trial requires 10 participants across one research centre."

Answered by AI

Is recruitment currently open for this clinical experiment?

"According to the clinicaltrials.gov, this research is presently in progress with recruitment underway. The trial was initially made public on March 1st 2023 and it has been revised most recently on June 1st 2023."

Answered by AI
~1 spots leftby Jun 2024